G

Genenta Science SpA

GNTA

4.43000
USD
0
(0.00%)
Market Closed
Volume
509
EPS
0
Div Yield
0
P/E
-8
Market Cap
97,460,725
Related Instruments
B
BEAM
-1.310
(-4.14%)
30.330 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
O
ORGO
-0.24000
(-7.97%)
2.77000 USD
Q
QURE
-0.14500
(-1.89%)
7.51000 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
V
VKTX
-2.380
(-4.18%)
54.610 USD
V
VYNE
-0.06400
(-3.42%)
1.81000 USD
News

Title: Genenta Science SpA

Sector: Healthcare
Industry: Biotechnology
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.